Literature DB >> 2953863

HPLC analysis of somatostatin related peptides in putamen of Huntington's disease patients.

G Sperk, G P Reynolds, P Riederer.   

Abstract

Size exclusion high performance liquid chromatography of post mortem human putamen samples revealed three somatostatin-immunoreactive peaks. The two major peaks cochromatographed with synthetic somatostatin-14 and somatostatin-28, respectively whereas the presumed somatostatin precursor preceded these peaks. In 11 samples obtained post mortem from patients suffering from Huntington's Disease somatostatin-like immunoreactivity was increased by about 55% in the mean. This increase was mainly due to increases in somatostatin-14 and--to a minor extent--of somatostatin-28, whereas the presumed precursor was not significantly changed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2953863     DOI: 10.1007/bf01244106

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  19 in total

1.  Selective sparing of a class of striatal neurons in Huntington's disease.

Authors:  R J Ferrante; N W Kowall; M F Beal; E P Richardson; E D Bird; J B Martin
Journal:  Science       Date:  1985-11-01       Impact factor: 47.728

2.  Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.

Authors:  T L Perry; S Hansen; M Kloster
Journal:  N Engl J Med       Date:  1973-02-15       Impact factor: 91.245

3.  Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia.

Authors:  C B Nemeroff; W W Youngblood; P J Manberg; A J Prange; J S Kizer
Journal:  Science       Date:  1983-09-02       Impact factor: 47.728

4.  NADPH-diaphorase: a selective histochemical marker for striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities.

Authors:  S R Vincent; O Johansson; T Hökfelt; L Skirboll; R P Elde; L Terenius; J Kimmel; M Goldstein
Journal:  J Comp Neurol       Date:  1983-07-01       Impact factor: 3.215

5.  Huntington's disease is accompanied by changes in the distribution of somatostatin-containing neuronal processes.

Authors:  P E Marshall; D M Landis
Journal:  Brain Res       Date:  1985-03-11       Impact factor: 3.252

6.  Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia.

Authors:  E D Bird; L L Iversen
Journal:  Brain       Date:  1974-09       Impact factor: 13.501

7.  N-terminally extended somatostatin: the primary structure of somatostatin-28.

Authors:  L Pradayrol; H Jörnvall; V Mutt; A Ribet
Journal:  FEBS Lett       Date:  1980-01-01       Impact factor: 4.124

8.  Somatostatin is increased in the basal ganglia in Huntington disease.

Authors:  N Aronin; P E Cooper; L J Lorenz; E D Bird; S M Sagar; S E Leeman; J B Martin
Journal:  Ann Neurol       Date:  1983-05       Impact factor: 10.422

9.  A type of aspiny neuron in the rat neostriatum accumulates [3H]gamma-aminobutyric acid: combination of Golgi-staining, autoradiography, and electron microscopy.

Authors:  J P Bolam; D J Clarke; A D Smith; P Somogyi
Journal:  J Comp Neurol       Date:  1983-01-10       Impact factor: 3.215

10.  Release of somatostatin-28(1-12) from rat hypothalamus in vitro.

Authors:  C Bakhit; R Benoit; F E Bloom
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.